VAXIMM to Attend International Scientific and Industry Events
BASEL, Switzerland and MANNHEIM, Germany, May 27, 2021 (GLOBE NEWSWIRE) — VAXIMM AG, a Swiss/German…
BASEL, Switzerland and MANNHEIM, Germany, May 27, 2021 (GLOBE NEWSWIRE) — VAXIMM AG, a Swiss/German…
Oslo, 27 May 2021. PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) issue this…
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945…
COPENHAGEN, Denmark, May 27, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
COPENHAGEN, Denmark, May 27, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today…
Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate Two-stage…
COPENHAGEN, Denmark, May 27 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has entered…
EMPATHY global multi-center Phase 2 – 3 study, recruiting patients with COVID-19 infection, aiming to…
Pratteln, Switzerland, May 27, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces the invitation to its Annual…
SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals, Inc. (Nasdaq:…
CUPERTINO, Calif., May 26, 2021 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
Active discussions with FDA related to COVAXIN initiated late last year Master file submitted to…
NEW YORK, May 26, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”) today announced…
– Treatment with sotrovimab resulted in an 85% reduction in the risk of hospitalization or…
BARRIE, Ontario, May 26, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF)…
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 26, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
ERYTECH to Participate in Upcoming Virtual Investor Conferences in June Lyon (France) and Cambridge, MA…
New contraindication applies to a subset of patients with primary biliary cholangitis (PBC) with decompensated…
BOSTON, May 26, 2021 (GLOBE NEWSWIRE) — Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical…
THE WOODLANDS, Texas, May 26, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…